Search research articles
Contact Us
Filters
Showing results (1-10 of 90) with videos related to
Page
of 9
Sort By:
The Journal of Rheumatology. Supplement
|
September 19, 2002
Interleukin 1 or tumor necrosis factor-alpha: which is the real target in rheumatoid arthritis?
Jean-Michel Dayer
Best Practice & Research. Clinical Rheumatology
|
May 5, 2004
The process of identifying and understanding cytokines: from basic studies to treating rheumatic diseases
Jean-Michel Dayer
Joint Bone Spine
|
May 25, 2002
The saga of the discovery of IL-1 and TNF and their specific inhibitors in the pathogenesis and treatment of rheumatoid arthritis
Jean-Michel Dayer
Arthritis Research & Therapy
|
June 1, 2018
From supernatants to cytokines: a personal view on the early history of IL-1, IL-1Ra, TNF and its inhibitor in rheumatology
Jean-Michel Dayer
Arthritis and Rheumatism
|
March 29, 2002
Targeting interleukin-1 in the treatment of rheumatoid arthritis
Jean-Michel Dayer, Barry Bresnihan
Arthritis Research
|
July 12, 2002
The role of human T-lymphocyte-monocyte contact in inflammation and tissue destruction
Danielle Burger, Jean-Michel Dayer
Rheumatology (Oxford, England)
|
October 27, 2009
Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor
Jean-Michel Dayer, Ernest Choy
Annals of the New York Academy of Sciences
|
July 13, 2002
Cytokines, acute-phase proteins, and hormones: IL-1 and TNF-alpha production in contact-mediated activation of monocytes by T lymphocytes
Danielle Burger, Jean-Michel Dayer
Autoimmunity Reviews
|
July 10, 2003
High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation?
Danielle Burger, Jean-Michel Dayer
Methods in Molecular Medicine
|
November 7, 2007
Assays of T-cell contact dependent monocyte-macrophage functions
Danielle Burger, Jean-Michel Dayer
Page
of 9
Search research articles
Search
Showing results (1-10 of 90) with videos related to
Sort By:
Page
of 9
The Journal of Rheumatology. Supplement
|
September 19, 2002
Interleukin 1 or tumor necrosis factor-alpha: which is the real target in rheumatoid arthritis?
Jean-Michel Dayer
Best Practice & Research. Clinical Rheumatology
|
May 5, 2004
The process of identifying and understanding cytokines: from basic studies to treating rheumatic diseases
Jean-Michel Dayer
Joint Bone Spine
|
May 25, 2002
The saga of the discovery of IL-1 and TNF and their specific inhibitors in the pathogenesis and treatment of rheumatoid arthritis
Jean-Michel Dayer
Arthritis Research & Therapy
|
June 1, 2018
From supernatants to cytokines: a personal view on the early history of IL-1, IL-1Ra, TNF and its inhibitor in rheumatology
Jean-Michel Dayer
Arthritis and Rheumatism
|
March 29, 2002
Targeting interleukin-1 in the treatment of rheumatoid arthritis
Jean-Michel Dayer, Barry Bresnihan
Arthritis Research
|
July 12, 2002
The role of human T-lymphocyte-monocyte contact in inflammation and tissue destruction
Danielle Burger, Jean-Michel Dayer
Rheumatology (Oxford, England)
|
October 27, 2009
Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor
Jean-Michel Dayer, Ernest Choy
Annals of the New York Academy of Sciences
|
July 13, 2002
Cytokines, acute-phase proteins, and hormones: IL-1 and TNF-alpha production in contact-mediated activation of monocytes by T lymphocytes
Danielle Burger, Jean-Michel Dayer
Autoimmunity Reviews
|
July 10, 2003
High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation?
Danielle Burger, Jean-Michel Dayer
Methods in Molecular Medicine
|
November 7, 2007
Assays of T-cell contact dependent monocyte-macrophage functions
Danielle Burger, Jean-Michel Dayer
Page
of 9